logo
Baird upgrades this fintech stock, calls for more than 30% upside

Baird upgrades this fintech stock, calls for more than 30% upside

CNBC14-07-2025
There's a rosy outlook ahead for nCino , according to Baird. The bank upgraded the financial technology stock to outperform rating from neutral. Analyst Joe Vruwink new price target of $38, up from $30, implies potential upside of 32%. Vruwink pointed out that the backdrop looks extremely favorable for nCino. Moreover, the company's management appears to be more positive about reaching its goals. "Current setup has many parallels to our favorite stock calls: macro/spend conditions likely turning higher, 'mechanical' growth accelerants, GTM catalysts, new product momentum…all with expectations having reset lower, yielding (we believe) the best estimate upside argument in years," Vruwink wrote. "Recent travel with management underscored execution is key; many details shared are consistent with prior messaging, though confidence/enthusiasm around changes adds conviction." The company appears to be "well underway" on many initiatives that should reaccelerate its subscription growth into double digits on a year-over-year basis. Meanwhile, nCino's management is also confident it can achieve the so-called "Rule of 40" — or have a combined revenue growth rate and profit margin that exceeds 40%. Baird added that now presents an opportune time to buy into nCino, given that the company has reached an important crux in its thesis. "nCino undertook material reset in financial communications entering FY26 (Jan), and while short-term negative for the stock, we view this as a turning point in the investment case (stock now back to within 5-10% of late-March levels on relative basis)," he wrote. "In analyzing comparable episodes in small-cap vertical software, those that come back from the abyss (i.e., inflect growth rates closer to pre-reset levels) are able to fully recapture valuation (at pre-reset level)." The stock rose more than 2% following the upgrade. Shares of nCino have slipped 14% this year. NCNO YTD mountain NCNO YTD chart Analysts are mostly on the sidelines when it comes to nCino. LSEG data shows that 11 of 17 analysts covering the stock rate it a hold. Another six have a buy rating.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cigna beats profit estimate on robust health services growth
Cigna beats profit estimate on robust health services growth

Yahoo

time21 minutes ago

  • Yahoo

Cigna beats profit estimate on robust health services growth

(Reuters) -Cigna beat Wall Street estimate for second-quarter profit on Thursday, helped by strength in its pharmacy benefit management business. It is one of the last health insurers to report quarterly results for the sector, which has been bogged down by persistently high medical costs in government-backed plans. Cigna, however, is insulated from such cost pressures as it recently sold its Medicare business to Health Care Service Corp. It banks more on its pharmacy benefit management and commercial health insurance businesses. "Our performance in the second quarter reflects our disciplined execution and the strength of our business mix," said CEO David Cordani. Revenue from its Evernorth healthcare services unit, which includes Cigna's pharmacy benefit management business, rose 17% to $57.83 billion during the quarter. Pharmacy benefit managers help negotiate drug prices and coverage with manufacturers on behalf of employers and health plan clients. PBMs' business practices, however, have drawn increasing scrutiny in recent years from U.S. lawmakers looking to lower drug prices, state attorneys generals and from the Federal Trade Commission, which released a report earlier this year accusing PBMs of inflating drug costs. Cigna's adjusted profit of $7.20 per share topped analysts' average estimate of $7.15 per share, according to data compiled by LSEG. The company maintained its annual adjusted profit forecast of at least $29.60 per share, while analysts expect $29.68 per share. For the quarter, it reported a medical care ratio — the percentage of premiums spent on medical care — of 83.2%, up from 82.3% a year earlier, but in line with analysts' estimate. The company said the increase was due to higher stop-loss medical costs. Stop-loss insurance plans help protect health plan sponsors, typically an employer, when medical claims pass a pre-designated threshold. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Puma Shares Plunge 17% After Outlook Slashed on Tariff Impact
Puma Shares Plunge 17% After Outlook Slashed on Tariff Impact

Yahoo

time4 hours ago

  • Yahoo

Puma Shares Plunge 17% After Outlook Slashed on Tariff Impact

Puma (PMMAF, Financials) shares tumbled as much as 18% before finishing 17% lower on Friday after the firm warned that its profits will fall because of rising U.S. import tariffs and problems within the German sportswear business now thinks that full-year sales will drop by a low double-digit amount and that it will lose money in 2025. This is a big change from its earlier prediction of up to 525 million ($614 million) in Hoeld, who became CEO on July 1 to spearhead a turnaround, said, We need to take a hard look at ourselves. Hoeld said in a media teleconference that Puma didn't live up to its own goals and that weak brand momentum, problems with channel mix, and too much inventory were among said that second-quarter revenues declined 2% year over year, to 1.94 billion ($2.27 billion), which was less than analysts had expected, which was 2.06 billion. The adjusted operating profit went from a profit of 13.2 million to a loss of 13.2 million. The company also had one-time costs of 84.6 million connected to its attempts to minimize in North America fell by 9%, while sales in Europe and Asia-Pacific also fell, which caused the said it sent more shipments to the U.S. ahead of projected tariff hikes, which caused its inventory levels to rise. Even though the company plans to raise prices in the fourth quarter, it thinks tariffs will cost them 80 million in gross profit in said at the beginning of this year that it would wait for bigger American brands to raise prices in the American market. "We don't want to be the leader," CFO Markus Neubrand stated in May. This article first appeared on GuruFocus. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store